Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Lucky 7 diabetes meds to join blockbuster club by 2020
Fierce Pharma Marketing
Tue, 05/12/15 - 04:27 pm
Tags:
diabetes, Sanofi, Lantus, Merck, Januvia, Eli Lilly, Humalog, Novo Nordisk, Xultophy, Tresiba
Former Novo exec Schultz will become a CEO after all—just at another pharma
BioPharma Dive
Thu, 05/7/15 - 11:00 am
Tags:
Novo Nordisk, Pharma CEOs, Lundbeck, Kåre Schultz
Novo pumps up hemophilia drug production with $225M plant
Fierce Pharma
Mon, 05/4/15 - 11:28 am
Tags:
Novo Nordisk, hemophilia, drug manufacturing
Novo's purported CEO-to-be is out the door amid executive reshuffle
Fierce Pharma
Thu, 04/30/15 - 10:33 am
Tags:
Novo Nordisk, Pharma CEOs, Kåre Schultz
Roche, Amgen, Novo top the ranks in biologics sales, with AbbVie, Sanofi close behind
Fierce Pharma
Mon, 04/27/15 - 09:12 pm
Tags:
Roche, Amgen, Novo Nordisk, AbbVie, Sanofi
What Novo Nordisk's Entry Into The Obesity Space Means To The Sector
Seeking Alpha
Fri, 04/24/15 - 11:03 am
Tags:
Novo Nordisk, obesity, Saxenda
Eyeing big niche in obesity, Novo rolls out Saxenda at $1,000 per month
Fierce Pharma
Wed, 04/22/15 - 01:55 pm
Tags:
Novo Nordisk, Saxenda, obesity
Novo Nordisk Quietly Becoming Big Player In Obesity Space
Seeking Alpha
Fri, 04/10/15 - 09:27 am
Tags:
Novo Nordisk, obesity, Saxenda
Novo Nordisk's Tresiba news a black cloud for Sanofi's new CEO
Fierce Pharma
Fri, 03/27/15 - 09:44 pm
Tags:
Novo Nordisk, Tresiba, Sanofi, Lantus, Olivier Brandicourt
Novo Nordisk filing move brings Tresiba closer to U.S. market
Yahoo/Reuters
Thu, 03/26/15 - 09:28 pm
Tags:
Novo Nordisk, Tresiba, insulin, diabetes
Bristol-Myers buys rights to Novo Nordisk immune system project
Yahoo/Reuters
Tue, 03/24/15 - 10:30 am
Tags:
Novo Nordisk, Bristol-Myers Squibb, autoimmune disease
Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better"
Forbes
Fri, 03/20/15 - 08:20 am
Tags:
Novo Nordisk, diabetes, clinical trials, diversity
How Novo Nordisk plans to keep its eyes on the diabetes prize
BioPharma Dive
Wed, 03/18/15 - 11:38 am
Tags:
Novo Nordisk, diabetes, Saxenda
Novo Nordisk Readies For Saxenda Launch - Investors Need To Keep Expectations Realistic
Seeking Alpha
Tue, 03/10/15 - 08:28 am
Tags:
Novo Nordisk, Saxenda, drug launches
FDA OKs Sanofi's Toujeo. Will a diabetes drug price war follow?
Fierce Biotech
Thu, 02/26/15 - 10:00 am
Tags:
Sanofi, diabetes, Toujeo, drug pricing, Lantus, Tresiba, Novo Nordisk
Novo-Nordisk's Oral GLP-1 Diabetes Treatment: An Update
Seeking Alpha
Sat, 02/21/15 - 09:38 am
Tags:
Novo Nordisk, diabetes, GLP-1 agonist, semaglutide
Patient groups still think ViiV is tops, with Novo and AbbVie close behind
Fierce Pharma Marketing
Wed, 02/11/15 - 09:47 am
Tags:
ViiV, Novo Nordisk, AbbVie, patients
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
Tags:
R&D, Merck, Novo Nordisk, Amgen, Sanofi, Ono Pharmaceutical
Sanofi undertakes major sales reorg of US diabetes business
BioPharma Dive
Tue, 02/10/15 - 10:39 am
Tags:
Sanofi, Novo Nordisk, diabetes, reorganization
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
Tags:
patents, Big Pharma, Abilify, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Crestor, Eli Lilly, Gilead Sciences, GSK, Harvoni, Hospira, Merck, Novo Nordisk, Pfizer, Sovaldi, Tecfidera

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.